Cargando…

In vivo CRISPR screens identify RhoV as a pro‐metastasis factor of triple‐negative breast cancer

Metastasis is the main death reason for triple‐negative breast cancer (TNBC). Thus, identifying the driver genes associated with metastasis of TNBC is urgently needed. CRISPR screens have dramatically enhanced genome editing and made it possible to identify genes associated with metastasis. In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Ming‐Liang, Gong, Yue, Ji, Peng, Hu, Xin, Shao, Zhi‐Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236621/ https://www.ncbi.nlm.nih.gov/pubmed/36898847 http://dx.doi.org/10.1111/cas.15783

Ejemplares similares

Regulation and functions of RhoU and RhoV
por: Hodge, Richard G., et al.
Publicado: (2017)

Atypical RhoV and RhoU GTPases control development of the neural crest
por: Faure, Sandrine, et al.
Publicado: (2011)

In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer
por: Ji, Peng, et al.
Publicado: (2022)

Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
por: Chen, Hongjin, et al.
Publicado: (2021)

RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway
por: Zhang, Deyu, et al.
Publicado: (2021)

Prognostic significance of the rho GTPase RHOV and its role in tumor immune cell infiltration: a comprehensive pan‐cancer analysis
por: Qin, Qin, et al.
Publicado: (2023)

Exosomal hsa_circ_0000519 modulates the NSCLC cell growth and metastasis via miR-1258/RHOV axis
por: Wang, Rui, et al.
Publicado: (2022)

Combined in vitro/in vivo genome-wide CRISPR screens in triple negative breast cancer identify cancer stemness regulators in paclitaxel resistance
por: Yan, Gang, et al.
Publicado: (2023)

A CRISPR Activation Screen Identifies an Atypical Rho GTPase That Enhances Zika Viral Entry
por: Luu, Anh Phuong, et al.
Publicado: (2021)

SDF-1 expression and tumor-infiltrating lymphocytes identify clinical subtypes of triple-negative breast cancer with different responses to neoadjuvant chemotherapy and survival
por: Wang, Ruo-Xi, et al.
Publicado: (2022)

Prediction of axillary lymph node metastasis in triple-negative breast cancer by multi-omics analysis and an integrated model
por: Li, Si-Yuan, et al.
Publicado: (2022)

RNAi screens for Rho GTPase regulators of cell shape and YAP/TAZ localisation in triple negative breast cancer
por: Pascual-Vargas, Patricia, et al.
Publicado: (2017)

Methionine deprivation suppresses triple-negative breast cancer metastasis in vitro and in vivo
por: Jeon, Hyein, et al.
Publicado: (2016)

Genome-wide CRISPR/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasis
por: Xu, Wen Wen, et al.
Publicado: (2023)

An In Vivo CRISPR Screen Identifies Stepwise Genetic Dependencies of Metastatic Progression
por: Scheidmann, Manuel C., et al.
Publicado: (2022)

ARAP1 negatively regulates stress fibers formation and metastasis in lung adenocarcinoma via controlling Rho signaling
por: Zhang, Zhengzheng, et al.
Publicado: (2023)

A new prognostic model for RHOV, ABCC2, and CYP4B1 to predict the prognosis and association with immune infiltration of lung adenocarcinoma
por: Li, Qiao, et al.
Publicado: (2023)

Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer
por: Lian, Bi, et al.
Publicado: (2020)

In vivo genome-wide CRISPR screening identifies ZNF24 as a negative NF-κB modulator in lung cancer
por: Liu, Lu, et al.
Publicado: (2022)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

AAV-mediated direct in vivo CRISPR screen identifies functional suppressors in glioblastoma
por: Chow, Ryan D., et al.
Publicado: (2017)

In Vivo Genome-Wide CRISPR Activation Screening Identifies Functionally Important Long Noncoding RNAs in Hepatocellular Carcinoma
por: Wong, Lok-Sze, et al.
Publicado: (2022)

OBSCN restoration via OBSCN-AS1 long-noncoding RNA CRISPR-targeting suppresses metastasis in triple-negative breast cancer
por: Guardia, Talia, et al.
Publicado: (2023)

Heparanase from triple-negative breast cancer and platelets acts as an enhancer of metastasis
por: Yang, Wen-Jing, et al.
Publicado: (2020)

Editorial: Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy
por: Deng, Xiyun, et al.
Publicado: (2022)

Conceptualizing the complexity of ferroptosis to treat triple-negative breast cancer: theory-to-practice
por: Zhang, Hang, et al.
Publicado: (2023)

In vivo validation of metastasis-regulating microRNA-766 in human triple-negative breast cancer cells
por: Oh, Keunhee, et al.
Publicado: (2017)

The 3′UTR signature defines a highly metastatic subgroup of triple-negative breast cancer
por: Wang, Lei, et al.
Publicado: (2016)

Gastric Metastasis of Triple Negative Invasive Lobular Carcinoma
por: Geredeli, Caglayan, et al.
Publicado: (2015)

Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology
por: Su, Guan-Hua, et al.
Publicado: (2022)

Calcifications in triple-negative breast cancer: Molecular features and treatment strategies
por: Lin, Cai-Jin, et al.
Publicado: (2023)

Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research
por: Pont, Mariona, et al.
Publicado: (2023)

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer
por: Xiao, Yi, et al.
Publicado: (2022)

TAB3 O-GlcNAcylation promotes metastasis of triple negative breast cancer
por: Tao, Tao, et al.
Publicado: (2016)

Integrated in vivo genetic and pharmacologic screening identifies co-inhibition of EGRF and ROCK as a potential treatment regimen for triple-negative breast cancer
por: Iskit, Sedef, et al.
Publicado: (2016)

A CRISPR platform for targeted in vivo screens identifies Toxoplasma gondii virulence factors in mice
por: Young, Joanna, et al.
Publicado: (2019)

Rho GTPases: Anti- or Pro-neoplastic Targets?
por: Zandvakili, Inuk, et al.
Publicado: (2016)

FAK is Required for Tumor Metastasis-Related Fluid Microenvironment in Triple-Negative Breast Cancer
por: Pan, Mei-Ren, et al.
Publicado: (2019)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Recovering false negatives in CRISPR fitness screens with JLOE
por: Dede, Merve, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0kekcga9b7uh626b38jh66612o